Search Results

Implementation of Risk-Stratified Breast Cancer Prevention With a Polygenic Risk Score Test in Clinical Practice.

• Authors : Padrik P; OÜ Antegenes, Tartu, Estonia.; Clinic of Hematology and Oncology, Tartu University Hospital, Tartu, Estonia.

• Source: Breast cancer : basic and clinical research [Breast Cancer (Auckl)] 2023 Oct 12; Vol. 17, pp. 11782234231205700. Date of Electronic Publication: 2023 Oct 12 (Print Publication: Publisher: SAGE Publications Country of Publication: United States NLM ID: 101474356 Publication Model: eCollection Cited Medium: Print ISSN:

Record details

A Breast Cancer Polygenic Risk Score Is Feasible for Risk Stratification in the Norwegian Population.

• Authors : Akdeniz BC; Center for Bioinformatics, Department of Informatics, University of Oslo, 0313 Oslo, Norway.; Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Oslo University Hospital, University of Oslo, 4956 Oslo, Norway.

• Source: Cancers [Cancers (Basel)] 2023 Aug 16; Vol. 15 (16). Date of Electronic Publication: 2023 Aug 16.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print)

Record details

The Prevalence and Molecular Landscape of Lynch Syndrome in the Affected and General Population.

• Authors : Roht L; Department of Clinical Genetics, Institute of Clinical Medicine, University of Tartu, 50406 Tartu, Estonia.; Department of Clinical Genetics, Genetics and Personalized Medicine Clinic, Tartu University Hospital, 50406 Tartu, Estonia.

• Source: Cancers [Cancers (Basel)] 2023 Jul 18; Vol. 15 (14). Date of Electronic Publication: 2023 Jul 18.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print)

Record details

An experience- and preference-based EQ-5D-3L value set derived using 18 months of longitudinal data in patients who sustained a fracture: results from the ICUROS.

• Authors : Svedbom A; ICON, Stockholm, Sweden. .; Division of Dermatology and Venereology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden. .

Subjects: Health Status* ; Osteoporotic Fractures*; Humans

• Source: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2023 Apr; Vol. 32 (4), pp. 1199-1208. Date of Publisher: Springer Netherlands Country of Publication: Netherlands NLM ID: 9210257 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Evidence of overestimating prostate cancer mortality in Estonia: a population-based study.

• Authors : Innos K; Department of Epidemiology and Biostatistics, National Institute for Health Development, Tallinn, Estonia.; Paapsi K

Subjects: Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/diagnosis; Male ; Humans

• Source: Scandinavian journal of urology [Scand J Urol] 2022 Oct-Dec; Vol. 56 (5-6), pp. 359-364. Date of Electronic Publication: 2022 Sep 08.Publisher: Medical Journals Sweden AB Country of Publication: Sweden NLM ID: 101587186 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Physical-mental health comorbidity: A population-based cross-sectional study.

• Authors : Jürisson M; Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.; Pisarev H

Subjects: Mental Health*; Adult ; Aged

• Source: PloS one [PLoS One] 2021 Dec 02; Vol. 16 (12), pp. e0260464. Date of Electronic Publication: 2021 Dec 02 (Print Publication: 2021).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines' Side Effects.

• Authors : Riad A; Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic.; Department of Public Health, Faculty of Medicine, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic.

Subjects: COVID-19* ; Vaccines*/Vaccines*/Vaccines*/adverse effects; COVID-19 Vaccines

• Source: International journal of environmental research and public health [Int J Environ Res Public Health] 2021 Jul 25; Vol. 18 (15). Date of Electronic Publication: 2021 Jul 25.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238455 Publication Model: Electronic Cited Medium: Internet ISSN: 1660-4601

Record details

Leisure Time Physical Activity and Associated Factors among Adults in Estonia 2000-2018.

• Authors : Mikk M; Institute of Family Medicine and Public Health, University of Tartu, Ravila 19, 50411 Tartu, Estonia.; Ringmets I

Subjects: Leisure Activities* ; Motor Activity*; Adult

• Source: International journal of environmental research and public health [Int J Environ Res Public Health] 2021 Mar 18; Vol. 18 (6). Date of Electronic Publication: 2021 Mar 18.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238455 Publication Model: Electronic Cited Medium: Internet ISSN: 1660-4601

Record details

Circulating β cell-specific CD8 + T cells restricted by high-risk HLA class I molecules show antigen experience in children with and at risk of type 1 diabetes.

• Authors : Yeo L; Department of Immunobiology, Faculty of Life Sciences and Medicine, King's College London, London, UK.; National Institute of Health Research Biomedical Research Centre at Guy's and St Thomas' Hospital and King's College London, London, UK.

Subjects: CD8-Positive T-Lymphocytes/CD8-Positive T-Lymphocytes/CD8-Positive T-Lymphocytes/*immunology ; Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/*immunology ; Histocompatibility Antigens Class I/Histocompatibility Antigens Class I/Histocompatibility Antigens Class I/*immunology

• Source: Clinical and experimental immunology [Clin Exp Immunol] 2020 Mar; Vol. 199 (3), pp. 263-277. Date of Electronic Publication: 2019 Nov 10.Publisher: Oxford University Press Country of Publication: England NLM ID: 0057202 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Circulating β cell‐specific CD8+ T cells restricted by high‐risk HLA class I molecules show antigen experience in children with and at risk of type 1 diabetes.

• Authors : Yeo, L.^1,2 (AUTHOR); Pujol‐Autonell, I.¹ (AUTHOR); Baptista, R.² (AUTHOR)

• Source: Clinical & Experimental Immunology. Mar2020, Vol. 199 Issue 3, p263-277. 15p. 4 Charts, 3 Graphs.

Record details